DavidPaulFivensonMDBoard Certified in Immunodermatology

Clinical Trials

• A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE) Start of enrollment: 2005 Mar 01

  Completed

• Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers Start of enrollment: 2005 Dec 01

  Completed

  Phase 2

• The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis Start of enrollment: 2009 Nov 01

  Completed

  Phase 3

• LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) Start of enrollment: 2010 Sep 01

  Completed

  Phase 3

• Phase 3 Papulopustular Rosacea Study Start of enrollment: 2011 Dec 01

  Completed

  Phase 3

• LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris Start of enrollment: 2012 May 01

  Completed

  Phase 2

• LEO 90100 in the Treatment of Psoriasis Vulgaris Start of enrollment: 2012 May 01

  Completed

  Phase 2

• A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis Start of enrollment: 2013 Nov 01

  Completed

  Phase 3

• Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis Start of enrollment: 2015 Feb 01

  Completed

  Phase 3

• Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis Start of enrollment: 2017 Mar 21

  Completed

  Phase 3

• A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis Start of enrollment: 2017 Sep 21

  Completed

  Phase 1

• Join now to see all